Noninvasive serum steroid signatures of lateralization and coexisting cortisol excess in primary aldosteronism

Clicks: 9
ID: 339510
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #449 of 457 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 457 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
INTRODUCTION: Adrenal venous sampling (AVS) remains the gold standard for primary aldosteronism (PA) subtyping but is invasive and technically demanding. We investigated whether peripheral steroid profiles could serve as a noninvasive tool for PA subtyping, characterizing the presence of coexisting mild autonomous cortisol secretion (MACS), and predicting biochemical outcomes after adrenalectomy. METHODS: In total, 216 patients with PA who underwent AVS between 2018 and 2022 were enrolled. Serum steroid profiling quantified 19 adrenal steroids and 17 metabolic ratios using liquid chromatography-mass spectrometry. Feature selection was performed using random forest-based recursive feature elimination. Logistic regression models were developed to predict lateralized PA and postoperative biochemical outcomes. Model performance was evaluated using receiver operating characteristic analysis. RESULTS: Lateralized PA showed significantly higher aldosterone and 18-hydroxycortisol (18-OHF) (P<0.001) but lower 11-hydroxyandrostenedione (11-OHA4) (P=0.001) than bilateral PA. A three-steroid model (18-OHF, aldosterone, 11-OHA4) showed discrimination comparable to a clinical model based on serum potassium, plasma aldosterone concentration, and plasma renin activity (AUC 0.821 vs. 0.790; P=0.351). A combined model integrating the clinical parameters with 18-OHF and 11-OHA4 achieved the highest performance (AUC 0.852), significantly outperforming the clinical model (P=0.002). Patients with lateralized PA and MACS had higher 18-OHF levels (age/sex-adjusted P=0.038). Baseline steroid markers were not significantly associated with post-surgical biochemical success (P>0.05). CONCLUSION: Serum steroid profiling may facilitate the noninvasive identification of lateralized PA beyond clinical parameters alone. Coexisting MACS was associated with androgen suppression and altered steroid patterns, while the prognostic role of steroid profiles for treatment outcomes requires further investigation.
Reference Key
openalex_W7225729267 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag454
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.